Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IPI-504 in Metastatic Melanoma
NCT00627419Phase 2Terminated
- Sponsor
- Infinity Pharmaceuticals, Inc.
- Start
- Feb 2008
- Primary completion
- Oct 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of retaspimycin in melanoma, sponsored by Infinity Pharmaceuticals, Inc.. Started Feb 2008; status: terminated.
02
Drugs
retaspimycin
03
Conditions
melanoma
Beyond the preview
Go deeper on NCT00627419.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00627419.